US Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.

Press releases published on September 14, 2026

Sep. 14, 2026

Slate Medicines Appoints Kenneth Koblan, PhD, as Chief Scientific Officer

Indeterminate GlobeNewswire

Sep. 14, 2026

Soleo Health Expands Atlanta Footprint With Infusion Centers In Woodstock and Fayetteville, Georgia

Indeterminate GlobeNewswire

Sep. 14, 2026

Pharmazz, Inc. Receives U.S. FDA Orphan Drug Designation for Sovateltide for the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy (NHIE)

Indeterminate GlobeNewswire

Sep. 14, 2026

Hop Valley Brewing Co. Makes Its Downtown Eugene Comeback with New Pub at 5th Street Public Market

Indeterminate GlobeNewswire

Sep. 14, 2026

Lyell Immunopharma To Participate in the Baird 2026 Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 14, 2026

Cullinan Therapeutics to Host Virtual Analyst and Investor Event Today to Feature Zipalertinib Plus Chemotherapy Phase 3 REZILIENT3 Data Presented at the IASLC 2026 World Conference on Lung Cancer

Indeterminate GlobeNewswire

Sep. 14, 2026

Senseonics Announces Strategic Partnership with Beta Bionics to Integrate Eversense® 365 with the iLet® Bionic Pancreas

Indeterminate GlobeNewswire

Sep. 14, 2026

Pasithea Therapeutics Announces Presentation of Initial PAS-004 Clinical Data from Ongoing Phase 1/1b Clinical Trial in Adult NF1 Patients at the 2026 European Neurofibromatosis Conference

Indeterminate GlobeNewswire

Sep. 14, 2026

GeNeuro, Inc., an NRx Company (Nasdaq:NRXP) is awarded European Patent Rights for GNK-301, a novel drug candidate to treat Amyotrophic Lateral Sclerosis (ALS)

Indeterminate GlobeNewswire

Sep. 14, 2026

Sol y Vida Launches Nationwide Bilingual Telehealth Platform Built for Latino Communities

Indeterminate GlobeNewswire

Sep. 14, 2026

Cellectis Announces Strategic Transformation To In Vivo Gene Editing Company

Indeterminate GlobeNewswire

Sep. 14, 2026

Cellectis annonce sa transformation stratégique en société d'édition du génome in vivo

Indeterminate GlobeNewswire

Sep. 14, 2026

Unilabs Advances Digital Pathology Across Europe with Proscia, Shaping the Future of Precision Medicine

Indeterminate GlobeNewswire

Sep. 14, 2026

Unilabs treibt mit Proscia die digitale Pathologie in ganz Europa voran und gestaltet die Zukunft der Präzisionsmedizin

Indeterminate GlobeNewswire

Sep. 14, 2026

Unilabs accélère la transformation numérique de la pathologie européenne avec Proscia, pour façonner l'avenir de la médecine de précision

Indeterminate GlobeNewswire

Sep. 14, 2026

Beverly Wilshire Aesthetics Beverly Hills Medical Spa Announces Global Rebrand, Expanding Botox, Dermal Fillers, and Morpheus8 Services

Indeterminate GlobeNewswire